Feature

Senate sends 21st Century Cures bill to president


 

With little debate and less dissent, the Senate passed the 21st Century Cures bill and sent it to President Obama for his promised signature.

The legislation passed the House by an overwhelming 392-26 vote on Nov. 30. Key provisions of the bill (H.R. 34) include:

• Food and Drug Administration reforms, including expedited review for certain medical devices, streamlined review for drug/device combinations, and increased patient involvement in the drug approval process, with $500 million to implement the reforms.

• $4.8 billion over 10 years for key biomedical research efforts including the BRAIN Initiative, the Cancer Moonshot, and the Precision Medicine Initiative.

• $1 billion in grants to states over a 2-year period to help supplement opioid abuse prevention and treatment activities.

• Provisions to improve the interoperability of EHRs.

• Provisions to improve treatment of serious mental illness.

“This bipartisan legislation – which [Senate] Majority Leader Mitch McConnell [R-Ky.] has called ‘the most important legislation Congress will pass this year’ – will help us take advantage of the breathtaking advances in biomedical research and bring those innovations to doctors’ offices and patients’ medicine cabinets around the county,” Sen. Lamar Alexander (R-Tenn.), chair of the Senate Health, Education, Labor, and Pensions Committee, said in a statement.

idesignimages/ThinkStock
The Senate passed the bill 94-5 on Dec. 7. Sens. Elizabeth Warren (D-Mass.), Bernie Sanders (I-Vt.), Ron Wyden (D-Ore.), Jeff Merkley (D-Ore.), and Mike Lee (R-Utah), voted against the law, with most objecting that the legislation did not address key issues in the need to find cures for major diseases.

“The most important prescription drug-related crisis facing our country right now is the skyrocketing price of prescription drugs. This bill does not even deal with that issue,” Sen. Sanders said on the Senate floor. “How can we talk about a bill dealing with the pharmaceutical industry without addressing the elephant in the room, which is the fact that we pay the highest prices in the world for medicine?”

In his weekly address on Dec. 3, President Obama promised to “sign [the bill] as soon as it reaches my desk.”

Gregory Twachtman contributed to this report.

dfulton@frontlinemedcom.com

On Twitter @denisefulton

Recommended Reading

Direct-to-Consumer Marketing: Implications for Patient Care and Orthopedic Education
MDedge Surgery
Impact of a Musculoskeletal Clerkship on Orthopedic Surgery Applicant Diversity
MDedge Surgery
CMS offers lower-stress reporting options for MACRA in 2017
MDedge Surgery
GAO report calls out HHS for misdirecting ACA reinsurance funds
MDedge Surgery
Analysis: CMS expects no MACRA pay cut for most small practices
MDedge Surgery
Doctors have at least seven APM options in 2017
MDedge Surgery
Drug prices, not the health law, top voters’ health priorities for 2017
MDedge Surgery
Slavitt to Trump administration: Keep the CMS Innovation Center
MDedge Surgery
House passes 21st Century Cures bill
MDedge Surgery
Trump HHS nominee could curb regulations, reshape health insurance
MDedge Surgery